Ranger Biotechnologies A/S: Financial statements 2021
CVR: 32280404
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,708,942 and a net result of DKK 171,975 compared with DKK 0 the year before. That is an increase of 135% compared with the year before. Equity in the 2021 report amounted to DKK 889,341. The solvency ratio was 15.7%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 5,708,942
- Profit/Loss
- DKK 171,975
- Equity
- DKK 889,341
- Total Assets
- DKK 5,667,922
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 5.7M | 172K | 889K | 9 |
| 2020 | - | 2.4M | 0 | 717K | 3 |
| 2019 | - | 591K | -12.7M | 717K | 2 |
| 2018 | - | -832K | -975K | 13.4M | 1 |
| 2017 | - | -1.3M | -4.9M | 14.3M | 1 |
Official annual report
Find more companies like Ranger Biotechnologies A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Ranger Biotechnologies A/S has published its annual report for 2020. Gross profit came to DKK 2,429,278, and the net result was DKK 0.
About Ranger Biotechnologies A/S
Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.
